WallStSmart
ENOV

Enovis Corp

NYSE: ENOV · HEALTHCARE · MEDICAL DEVICES

$23.44
+4.22% today

Updated 2026-04-30

Market cap
$1.35B
P/E ratio
P/S ratio
0.60x
EPS (TTM)
$-20.72
Dividend yield
52W range
$21 – $38
Volume
1.0M

Enovis Corp (ENOV) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-17.36M$74.48M$-31.51M$38.29M$61.97M$57.15M$164.30M$362.17M$385.76M$303.81M$246.97M$218.77M$226.37M$130.95M$301.94M$356.10M$-55.86M$134.99M$113.50M$217.29M
Capital expenditures$10.24M$13.67M$20.11M$11.01M$12.53M$14.79M$83.59M$71.48M$81.34M$69.88M$63.25M$68.77M$69.65M$125.40M$114.78M$104.24M$105.45M$122.22M$180.71M$197.38M
Depreciation
Stock-based comp$11.33M$2.59M$3.14M$4.91M$9.37M$13.33M$17.58M$16.32M$19.02M$21.55M$25.10M$21.96M$28.91M$35.35M$38.95M$34.06M$29.66M$32.92M
Free cash flow$-27.59M$60.81M$-51.63M$27.28M$49.44M$42.37M$80.71M$290.69M$304.42M$233.94M$183.72M$150.00M$156.72M$5.55M$187.15M$251.86M$-161.31M$12.77M$-67.21M$19.92M
Investing cash flow
Financing cash flow
Dividends paid$38.55M$38.55B$17.45M$20.40M$3.85M$2.25B$896.74M$1.27B
Share repurchases
Debt repayment
Net change in cash$620.53M$-697.38M